![](/img/cover-not-exists.png)
A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML)
Marcé, Silvia, Cortés, Montserrat, Zamora, Lurdes, Cabezón, Marta, Grau, Javier, Millá, Fuensanta, Feliu, EvaristVolume:
99
Language:
english
Journal:
Experimental and Molecular Pathology
DOI:
10.1016/j.yexmp.2015.04.007
Date:
August, 2015
File:
PDF, 618 KB
english, 2015